Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 10, 2019

SELL
$18.5 - $25.47 $102,675 - $141,358
-5,550 Closed
0 $0
Q1 2019

Apr 02, 2019

SELL
$14.62 - $22.13 $1,973 - $2,987
-135 Reduced 2.37%
5,550 $117,000
Q2 2018

Jul 17, 2018

BUY
$36.15 - $52.5 $205,512 - $298,462
5,685 New
5,685 $286,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Dubuque Bank & Trust CO Portfolio

Follow Dubuque Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.